ROCKVILLE, Md., March 22, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its 2011 Annual Meeting of Shareholders will be held on Wednesday, May 25, 2011 at 10:00 a.m. EDT. The location of the meeting will be the Bethesda Marriott Hotel, 5151 Pooks Hill Road in Bethesda, Maryland.
About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in the areas of nicotine addiction and gram-positive bacterial infections. Nabi Biopharmaceuticals is currently developing NicVAX® (Nicotine Conjugate Vaccine), an innovative and proprietary investigational vaccine for treatment of nicotine addiction and prevention of smoking relapse. The company is headquartered in Rockville, Maryland. For additional information about Nabi Biopharmaceuticals, please visit .
CONTACT: Investor Relations 301-770-3099 www.nabi.com